Table III.
Univariate and multivariate analyses of factors affecting progression-free survival (PFS) in glioma patients.
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| Variables | HR (95% CI) | P-value | HR (95% CI) | P-value |
| Sex | 0.927 (0.635–1.355) | 0.696 | ||
| Age (years) | 1.122 (0.766–1.644) | 0.554 | ||
| Location | 1.089 (0.956–1.240) | 0.200 | ||
| Tumor size | 2.127 (1.441–3.140) | <0.001 | 1.658 (1.076–2.554) | 0.022 |
| Cystic change | 0.928 (0.618–1.395) | 0.720 | ||
| Necrosis | 1.226 (0.800–1.877) | 0.349 | ||
| WHO grade | 2.611 (1.725–3.952) | <0.001 | 2.118 (1.354–3.312) | 0.001 |
| KPS score | 0.922 (0.630–1.348) | 0.674 | ||
| BPTF expression | 2.023 (1.366–2.995) | <0.001 | 1.603 (1.020–2.521) | 0.041 |
HR, hazard ratio; CI, confidence interval. Bold indicates a statistically significant result.